Celine Lopez-Fombellida
Liege, WAL, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV.
Journal: eLife
Published: January 23, 2026
Doubling dolutegravir dosage reduces the viral reservoir in ART-treated people with HIV.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
No associations between HIV reservoir and inflammation in long-term virally suppressed dolutegravir-based ART-treated individuals.
Journal: Frontiers in immunology
Published: May 14, 2025
Persistent HIV-1 transcription during ART: time to reassess its significance?
Journal: Current opinion in HIV and AIDS
Published: March 19, 2024
IFNα induces CCR5 in CD4+ T-cells, causing its anti- HIV inefficiency and its subsequent pathogenic elevation, partially controlled by anti-HIV therapy.
Journal: Research square
Published: May 22, 2023
Early elevated IFNα is a key mediator of HIV pathogenesis.
Journal: Communications medicine
Published: May 03, 2023
IFNα induces CCR5 in CD4+ T cells of HIV patients causing pathogenic elevation.
Journal: Communications medicine
Published: May 03, 2023
Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
Journal: Frontiers in immunology
Published: February 01, 2022
Hurdles to HIV cure. Part 1 : the latent reservoirs
Journal: Revue medicale de Liege
Published: September 10, 2020
Hurdles to HIV cure. Part 2 : ongoing HIV replication despite therapy
Journal: Revue medicale de Liege
Published: September 10, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026